ALZPROTECT
Updated 669 days ago
- Age: 16 years
- ID: 12414075/119
85 Rue Nelson Mandela 59120 Loos France
Alzprotect is a biopharmaceutical company that develops drug candidates, from their discovery to clinical trials, for the treatment of neurodegenerative diseases including Alzheimer's disease (AD) and tauopathies such as Progressive Supranuclear Palsy (PSP)...
AlzProtect was founded in 2007 by André Delacourte, PhD, one of the pioneers in the molecular characterization of neurodegenerative diseases - tauopathies, amyloidopathies and synucleinopathies - and Patricia Melnyk, PhD, an expert in medicinal chemistry...
Alzprotect has developed specific global-level expertise in tauopathies, where neuronal degeneration is a consequence of an abnormal accumulation of hyperphosphorylated Tau proteins combined to neuroinflammation: Progressive Supranuclear Palsy (PSP) and Alzheimer's disease (AD).